Gregory M. Lucas

powered by
COS Expertise®
Johns Hopkins University
School of Medicine
Medicine
Infectious Diseases
Associate ProfessorAppointed: 2006

Mailing Address

1830 E. Monument Street
Room 435A
Baltimore, Maryland 21287
United States

Contact Information

Phone: (410) 614-0560
Fax: (410) 955-7889
glucas@jhmi.edu

Qualifications

Ph.D., Johns Hopkins University, Clinical Investigation, 2004.
M.D., Duke University, 1994.
B.S., University of Notre Dame, Biology, 1990.

Expertise and Research Interests

--HIV clinical outcomes
--Illicit drug use and HIV management
--Integrated care of HIV-infected drug users
--HIV and chronic kidney disease

Keywords

COS Keywords:

Clinical Medicine, Infectious Diseases or Agents, Medical Education.

Memberships

American College of Physicians
HIV Medical Association
Infectious Diseases Society of America

Honors and Awards

2004, Delta Omega Honorary Society in the Public Health, Alpha Chapter, Johns Hopkins University
1994, A.O.A. Medical Honor Society, Duke University

Previous Positions

2001-2006, Assistant Professor, Johns Hopkins University, School of Medicine, Medicine, Infectious Diseases

Funding Received

  • National Institute on Drug Abuse: Directly administered HIV therapy in methadone clinics, , 2005 to 2010.
  • Health Resources and Service Administration: Randomized trial of HIV-clinic-based buprenorphine vs. referred substance abuse care, , 2004 to 2009.
  • National Institute on Drug Abuse: Directly observed antiretroviral therapy in drug users, , 2002 to 2007.

Publications

  • Vlahov D, Galai N, Safaeian M, Galea S, Kirk GD, Lucas GM, Sterling TR (Jun 2005) Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodeficiency virus infection., American Journal of Epidemiology, 161 (11), 999-1012 Abstract
  • Moore RD, Keruly JC, Gebo KA, Lucas GM (Jun 2005) An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002., Journal of Acquired Immune Deficiency Syndromes (1999), 39 (2), 195-8 Abstract
  • Lucas GM (Apr 2005) Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven., The Journal of Antimicrobial Chemotherapy, 55 (4), 413-6 Abstract
  • Lucas GM, Wu AW, Cheever LW (Dec 2004) Adherence to antiretroviral therapy: an update of current concepts., Curr Hiv/aids Rep, 1 (4), 172-80 Abstract
  • Lucas GM, Gallant JE, Moore RD (Jul 2004) Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing., Aids (london, England), 18 (11), 1539-48 Abstract
  • Lucas GM, Weidle PJ, Hader S, Moore RD (Jun 2004) Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study., Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America., 38 Suppl 5, S409-13 Abstract
  • Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD (Feb 2004) Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study., Aids (london, England), 18 (3), 541-6 Abstract
  • Lucas GM, Chaisson RE, Moore RD, Survival in an urban HIV-1 clinic in the era of highly active antiretroviral therapy: A 5-year cohort study, Journal of Acquired Immune Deficiency Syndromes (1999), 33(3), 321-8, July 2003
  • Lucas GM, Flexner CW, Moore RD, Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden?, Aids Patient Care and Stds, 16(11), 527-35, November 2002 Abstract
  • Lucas GM, Gebo KA, Chaisson RE, Moore RD, Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic, Aids (London, England), 16(5), 767-74, March 2002
  • Lucas GM, Chaisson RE, Moore RD, Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenz, Aids (London, England), 15(13), 1679-86, September 2001
  • Lucas GM, Cheever LW, Chaisson RE, Moore RD, Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection, Journal of Acquired Immune Deficiency Syndromes: Jaids, 27(3), 251-9, 2001
  • Lucas GM, Tucker P, Merz WG, Primary cutaneous Aspergillus nidulans infection associated with a Hickman catheter in a patient with neutropenia, Clinical Infectious Diseases, 29(6), 1594-6, December 1999 Abstract
  • Lucas GM, Chaisson RE, Moore RD, Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions, Annals of Internal Medicine, 131(2), 81-7, July 1999 Abstract
  • Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD, Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes, Clinical Infectious Diseases, 26(5), 1127-33, 1998
  • White LE, Lucas G, Richards A, Purves D, Cerebral asymmetry and handedness, Nature, 368(6468), 197-8, March 1994 Abstract

Profile Details

Last Updated: 10/12/2007

COS Expertise ID #853243
Reference this profile directly: http://myprofile.cos.com/glucas